Clinical trial NCT01326663: Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.
Official title: A Double Blind Trial Of Divalproex Sodium For Affective Lability And Alcohol Use Following Traumatic Brain Injury
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Veterans
TBI
Alcoholism
Irritable Mood
Keywords: Veterans
TBI
Alcoholism
Mood
Lead sponsor: Denver Research Institute
Sponsor class: OTHER
First posted: 2011-03-31
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Despite the body's natural healing during the first year after a head injury, many veterans who have suffered even mild brain injuries find themselves easily upset or fearful as they go about their daily lives. While these reactions to the world around them were easily managed before the head injury, they now occur with little or no interruption and are exceedingly difficult to manage. Such reactions include a sense of always being upset or fearful that often makes it difficult to get along with family members, friends, coworkers, and employers. This may lead to broken marriages, unemployment, and even homelessness.

Some people with head injuries try to manage their unmanageable moods by drinking alcohol because it can create a sense of calm. However, alcohol's actions are short in duration. Most find that they have to drink more and more for a similar calming effect, and they soon become dependent on alcohol. This makes working and being part of their families even more difficult.

To treat the unmanageable mood, we tried a medicine called valproate, one that eases mood problems in people without head injury. We gave valproate to head injured persons with mood problems in a "non-blinded" study where both the doctor and the patient knew that the medicine was valproate and both were optimistic that it would work. In a small sample of eighteen people, 85% found mood relief and most of those either stopped drinking alcohol or drank much less than before. However, this might have been because both the doctor and patient were hopeful that the medication would make the patient feel better or because the medicine actually worked.

The only way to know for sure if the medicine works is to perform a study in which people receive either valproate or a sugar pill while neither they nor their doctor know which one they are taking. This is called a double blind study, as proposed here, and will involve nearly three times as many head injured persons as the first study.

If it is successful, this study will show that valproate treatment helps head injured people manage their moods and allows them to return to families, friends, and work. It will also show that they drink alcohol less or not at all, improving their health even further. Then doctors will know that they can use this medicine for large numbers of people who suffer from head injury and help them to lead normal lives. If the outcome of the study shows that the medicine works well, doctors can then use this medicine to treat people with head injury immediately after the study results are published.


Eligibility criteria: Inclusion Criteria:

* a history of remote (≥ 1 year prior to study enrollment) non-penetrating TBI
* currently using alcohol
* symptoms of affective lability: mood swings, irritability, frustration

Exclusion Criteria:

* a history of bipolar disorder or anxiety disorder prior to any head injury
* a history of head injury in which the cranium was opened either traumatically or surgically
* a history of stroke
* a history of seizure disorder other than those caused by ethanol withdrawal
* evidence of active liver disease
* current diagnosis or past history of major psychosis, the alcohol amnesic syndrome, or any type of dementia
* current suicidal/homicidal ideations
* any medical conditions that would constitute contraindications to treatment with divalproex sodium
* currently taking any medications that are known to affect the metabolism of divalproex sodium

Primary outcomes:
measure: Reduced Affective Lability
timeFrame: Study weeks 1-10
Secondary outcomes:
measure: Reduced Alcohol Use
timeFrame: Study weeks 1-10
Other outcomes:
Locations:
city: Denver
country: United States
facility: Denver Veteran's Affairs Medical Center
state: Colorado
Study officials:
References: